Best of ASCO - 2014 Annual Meeting

 

Welcome

Local-Regional

Head and Neck Cancer

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A double-blind, randomized pilot study of NS-21 in the prevention of radiation dermatitis for patients with head and neck cancer.

Chen-Hsi Hsieh

6065

A novel method of intra-arterial chemotherapy for oral cancer.

Masatoshi Ohmae

e18086

A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.

Shuchi Gulati

6074

A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).

Jochen H. Lorch

6071

A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.

Xu Shan Sun

6018

A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC).

Christian H.H Ottensmeier

6068

A retrospective analysis of adult head and neck rhabdomyosarcoma (HN RMS) from 1984-2017.

Shivali Barot

e18089

Adjuvant apatinib in nasopharyngeal carcinoma patients with residual Epstein-Barr virus DNA after curative radiotherapy: A phase IIa/IIb trial.

Jun Ma

e18063

Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH).

Yungan Tao

6076

BEST OF: A phase III study assessing the best of radiotherapy (Intensity Modulated RadioTherapy, IMRT) compared to the best of surgery (Trans-Oral Surgery, TOS) in patients with T1-T2, N0 oropharyngeal squamous cell carcinoma (OPSCC).

Christian Simon

TPS6098

Capecitabine efficacy and safety in patients with locally advanced nasopharyngeal cancer: Retrospective study.

Reyad Dada

e18070

Cisplatin (CIS) versus cetuximab (CET) with definitive concurrent radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC): An analysis of veteran’s health data.

Joshua Bauml

6073

Clinical characteristics and prognosis of nasopharyngeal carcinoma patients: A report of 479 cases.

Jingjing Zhang

e18082

De-escalation in HPV-negative locally advanced head and neck squamous cell cancer (LA-HNSCC) in patients after induction chemotherapy: A retrospective case series.

Ryan J. Brisson

e18090

Definitive cetuximab-based (CRT-CX) vs. non-cetuximab based chemoradiation (CRT) in older patients with squamous cell carcinoma of the head and neck (HNSCC): Analysis of the SEER-Medicare linked database.

Dan Paul Zandberg

6001

Diagnostic dilemma: Overlapping clinical and radiologic features of osteoradionecrosis and recurrent head and neck squamous cell carcinoma.

Andrea M Tufano

e18072

Differences in patterns of care in older vs. younger head and neck cancer patients.

Melissa Crawley

e18079

Evolution of induction chemotherapy in the pre- and post-taxane era for locally advanced laryngeal cancer: A National Cancer Data Base analysis.

Sagar Anil Patel

e18080

Impact of patient symptoms and caregiver tasks on psychological distress in caregivers for head and neck cancer (HNC).

Emily Castellanos

6070

IMRT combined with concurrent S-1 chemotherapy for locally advanced nasopharyngeal carcinoma: A prospective phase II study.

Tao Lv

e18085

Influence of hypothyroidism post chemo radiation on outcomes in head and neck cancer.

Tanmoy Kumar Mandal

e18066

Long term efficacy and safety of nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: A real world Indian experience.

Sundaram Subramanian

e18077

Long-term outcomes for re-irradiation of recurrent head-and-neck cancers: Report of acute and long-term toxicity.

Nima Aghdam

6077

Management of stage II nasopharyngeal carcinoma (NPC) in the US population: Retrospective analysis of the National Cancer Database (NCDB).

Omer Toor

e18088

Neck dissection rate in node positive human papillomavirus associated oropharyngeal carcinoma following chemoradiotherapy.

Sandro Porceddu

6067

Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.

Richard Bryan Bell

6011

New global prognosis score (GPSc) in resectable oral squamous cell carcinoma (OSCC): Joining up tumor and patient-related data.

Ursula Jariod-Ferrer

e18078

Outcomes of chemoradiation (CRT) for locoregionally advanced (LRA)squamous cell carcinoma of the head and neck (SCCHN): Outcomes with weekly cisplatin (WC) in an academic community based hospital.

Bruce Brockstein

e18081

Phase II study: Induction chemotherapy and transoral surgery as definitive treatment (Tx) for locally advanced oropharyngeal squamous cell carcinoma (OPSCC): A novel approach.

Robert S. Siegel

6004

Phase II trial of high-dose melatonin oral gel for the prevention and treatment of oral mucositis in H&N cancer patients undergoing chemoradiation (MUCOMEL).

Alicia Lozano

6007

Post-treatment evaluation of head and neck cancer patients in the era of advanced imaging and value-based care.

Thomas Hirsch

6079

Preliminary toxicity data from the combination of pembrolizumab and definitive-dose radiotherapy for locally advanced head and neck cancer with contraindication to cisplatin therapy.

Jared Weiss

6069

Quality of life (QoL) analysis in HPV positive oropharynx cancer (HPVOPC) patients in a randomized deintensification trial.

Michael Hwang

e18068

Regional lymph node metastases oncogenic mutations compared to primary tumors in HPV+ oropharynx patients.

John F. Deeken

6078

Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

Vijay Maruti Patil

6000

Results of a randomized, placebo (PBO) controlled, double-blind P2b trial of GC4419 (avisopasem manganese) to reduce duration, incidence and severity and delay onset of severe radiation-related oral mucositis (SOM) in patients (pts) with locally advanced squamous cell cancer of the oral cavity (OC) or oropharynx (OP).

Carryn M. Anderson

6006

Safety and effectiveness of transoral surgery for superficial head and neck cancer: The National Registration Survey of superficial head and neck cancer in Japan.

Chikatoshi Katada

6066

Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504.

Robert L. Ferris

6010

Suboptimal regimens in sequential treatment (ST) with ICT (induction chemotherapy) followed by CCRT (concomitant chemotherapy) in "real life" patients with locally advanced pharyngo-laryngeal squamous-cell carcinoma (LAPLSCC) and prognosis.

Carmen Orte

6075

The effect of MATE1 polymorphisms on cisplatin efficacy in patients with head and neck cancer.

Daniel Adam Breadner

e18069

The influence of age on treatment compliance and outcome in patients with stage IV head and neck cancer treated with radiotherapy and concurrent cisplatin or cetuximab.

Vittoria G. Espeli

e18065

The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma.

Roy Xiao

6072

The retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100mg/m2 to 80mg/m2 for head and neck cancer (HNC) patients.

Tomoyo Oguri

e18067

Treatment deintensification to surgery only for stage I human papillomavirus-associated oropharyngeal cancer.

John David Cramer

6003

Treatments for locally advanced oropharyngeal cancer: A systematic review of clinical effectiveness and cost-effectiveness.

Chuong Ho

e18071

Tumour response and survival of treatment-naïve head and neck cancer patients treated with nimotuzumab: A systematic review and meta-analysis.

Sundaram Subramanian

e18083

Use of percutaneous endoscopic gastrostomy (PEG) tube feeding support in head and neck cancer patients.

Ramla Namisango Kasozi

e18062

Variations in the use of definitive chemoradiotherapy and immunoradiotherapy for patients with locally advanced head and neck cancer.

Shiva Kumar Reddy Mukkamalla

e18074